Scientists and engineers are inherently resistant to top-down change efforts – they are highly educated and intellectually-strong individuals who “don’t like being told by someone else what to do”. Many change initiatives in scientific and technical organizations have failed to even get off the ground properly. And those that did often stalled or plateaued with few of the planned benefits achieved. Nevertheless, sustainable and valuable change can be achieved by combining the unique characteristics of each organization’s culture, people and business with an appropriate change process for its situation and needs.
As six months have now elapsed since its initial publication in the peer-reviewed journal Research-Technology Management (RTM), we reproduce here the full text of the paper authored by myself and Timo Lotta. This paper documents a comprehensive case study of how Orion Pharma’s R&D organization was transformed to implement a … Continue reading →
Timo Lotta and I are pleased to announce the publication of our paper in the peer-reviewed journal Research-Technology Management (RTM) . This paper documents a comprehensive case study of how Orion Pharma’s R&D organization was transformed to implement a results-oriented “open R&D” model through proactive culture change … Continue reading →
Initiatives to cultivate innovation are rapidly proliferating. From my regular dialogue with Marketing and R&D executives of science/technology-based organizations, I notice many initiatives are built on at least one of these underlying assumptions: Innovation can be Outsourced Ideation = Innovation Technological Novelty = Innovation Per se, these assumptions are perfectly … Continue reading →
The BioPharma industry is in the midst of disruptive renewal. Executives and managers need to be Change Leaders. But leading change in BioPharma involves some additional challenges. … Continue reading →
Throughout the past two decades, biomedical companies have learnt painfully that industrialized management of R&D does not deliver. Using illustrations from the pharmaceutical sector, this article looks back on the principal approaches that were adopted to transform R&D productivity over this period. We reflect on what has definitely not worked … Continue reading →
Whether driven by pre-emptive thinking or business pressures, many scientific and technical organizations need to raise their game. Under the banner of contemporary catchphrases such as “open innovation”, “customer centric product development”, “strategic outsourcing”, “customer partnering” and “R&D transformation”, such organizations have been striving to initiate change programs for achieving … Continue reading →